Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of ...
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of ...
Cell therapy first reached patients as treatments for cancer. Artiva Biotherapeutics is part of a growing group of companies working ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.